Sherblom James's Form 4/A amendment
AmendedComera Life Sciences Holdings, Inc. (CMRA) · filed Feb 14, 2023
- Accession no.
- 0001062993-23-003511
- Filed
- Feb 14, 2023, 5:47 PM ET
- Trade date
- Jan 4, 2023
- Filing delay
- 41 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 6, 2023
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $99.7K. It was filed 41 days after the trade.
This amendment replaces 0001062993-23-000610 (filed Jan 6, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherblom JamesCIK 0001926230 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | PPurchaseAcquired | +81,081 | $1.23 | +$99,729.63 | 452,244 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | PPurchaseAcquired | +162,162 | $0.25 | +$20,270.25 | 81,081 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.